Desloratadine (patient information)
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Gloria Picoy [2]
Disclaimer
WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.
Overview
Desloratadine (patient information) is an antihistamine that is FDA approved for the treatment of seasonal allergic rhinitis, perennial allergic rhinitis and chronic idiopathic urticaria. Common adverse reactions include pharyngitis, dry mouth, myalgia, fatigue, somnolence and dysmenorrhea.
Adult Indications and Dosage
FDA-Labeled Indications and Dosage (Adult)
There is limited information regarding Desloratadine (patient information) FDA-Labeled Indications and Dosage (Adult) in the drug label.
Off-Label Use and Dosage (Adult)
Guideline-Supported Use
There is limited information regarding Off-Label Guideline-Supported Use of Desloratadine (patient information) in adult patients.
Non–Guideline-Supported Use
There is limited information regarding Off-Label Non–Guideline-Supported Use of Desloratadine (patient information) in adult patients.
Pediatric Indications and Dosage
FDA-Labeled Indications and Dosage (Pediatric)
There is limited information regarding Desloratadine (patient information) FDA-Labeled Indications and Dosage (Pediatric) in the drug label.
Off-Label Use and Dosage (Pediatric)
Guideline-Supported Use
There is limited information regarding Off-Label Guideline-Supported Use of Desloratadine (patient information) in pediatric patients.
Non–Guideline-Supported Use
There is limited information regarding Off-Label Non–Guideline-Supported Use of Desloratadine (patient information) in pediatric patients.
Contraindications
There is limited information regarding Desloratadine (patient information) Contraindications in the drug label.
Warnings
There is limited information regarding Desloratadine (patient information) Warnings' in the drug label.
Adverse Reactions
Clinical Trials Experience
There is limited information regarding Desloratadine (patient information) Clinical Trials Experience in the drug label.
Postmarketing Experience
There is limited information regarding Desloratadine (patient information) Postmarketing Experience in the drug label.
Drug Interactions
There is limited information regarding Desloratadine (patient information) Drug Interactions in the drug label.
Use in Specific Populations
Pregnancy
Pregnancy Category (FDA):
There is no FDA guidance on usage of Desloratadine (patient information) in women who are pregnant.
Pregnancy Category (AUS):
There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Desloratadine (patient information) in women who are pregnant.
Labor and Delivery
There is no FDA guidance on use of Desloratadine (patient information) during labor and delivery.
Nursing Mothers
There is no FDA guidance on the use of Desloratadine (patient information) in women who are nursing.
Pediatric Use
There is no FDA guidance on the use of Desloratadine (patient information) in pediatric settings.
Geriatic Use
There is no FDA guidance on the use of Desloratadine (patient information) in geriatric settings.
Gender
There is no FDA guidance on the use of Desloratadine (patient information) with respect to specific gender populations.
Race
There is no FDA guidance on the use of Desloratadine (patient information) with respect to specific racial populations.
Renal Impairment
There is no FDA guidance on the use of Desloratadine (patient information) in patients with renal impairment.
Hepatic Impairment
There is no FDA guidance on the use of Desloratadine (patient information) in patients with hepatic impairment.
Females of Reproductive Potential and Males
There is no FDA guidance on the use of Desloratadine (patient information) in women of reproductive potentials and males.
Immunocompromised Patients
There is no FDA guidance one the use of Desloratadine (patient information) in patients who are immunocompromised.
Administration and Monitoring
Administration
There is limited information regarding Desloratadine (patient information) Administration in the drug label.
Monitoring
There is limited information regarding Desloratadine (patient information) Monitoring in the drug label.
IV Compatibility
There is limited information regarding the compatibility of Desloratadine (patient information) and IV administrations.
Overdosage
There is limited information regarding Desloratadine (patient information) overdosage. If you suspect drug poisoning or overdose, please contact the National Poison Help hotline (1-800-222-1222) immediately.
Pharmacology
There is limited information regarding Desloratadine (patient information) Pharmacology in the drug label.
Mechanism of Action
There is limited information regarding Desloratadine (patient information) Mechanism of Action in the drug label.
Structure
There is limited information regarding Desloratadine (patient information) Structure in the drug label.
Pharmacodynamics
There is limited information regarding Desloratadine (patient information) Pharmacodynamics in the drug label.
Pharmacokinetics
There is limited information regarding Desloratadine (patient information) Pharmacokinetics in the drug label.
Nonclinical Toxicology
There is limited information regarding Desloratadine (patient information) Nonclinical Toxicology in the drug label.
Clinical Studies
There is limited information regarding Desloratadine (patient information) Clinical Studies in the drug label.
How Supplied
There is limited information regarding Desloratadine (patient information) How Supplied in the drug label.
Storage
There is limited information regarding Desloratadine (patient information) Storage in the drug label.
Images
Drug Images
{{#ask: Page Name::Desloratadine (patient information) |?Pill Name |?Drug Name |?Pill Ingred |?Pill Imprint |?Pill Dosage |?Pill Color |?Pill Shape |?Pill Size (mm) |?Pill Scoring |?NDC |?Drug Author |format=template |template=DrugPageImages |mainlabel=- |sort=Pill Name }}
Package and Label Display Panel
{{#ask: Label Page::Desloratadine (patient information) |?Label Name |format=template |template=DrugLabelImages |mainlabel=- |sort=Label Page }}
Patient Counseling Information
There is limited information regarding Desloratadine (patient information) Patient Counseling Information in the drug label.
Precautions with Alcohol
Alcohol-Desloratadine (patient information) interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.
Brand Names
There is limited information regarding Desloratadine (patient information) Brand Names in the drug label.
Look-Alike Drug Names
There is limited information regarding Desloratadine (patient information) Look-Alike Drug Names in the drug label.
Drug Shortage Status
Price
References
The contents of this FDA label are provided by the National Library of Medicine.
Why this medication is prescribed
Desloratadine is used to relieve hay fever and allergy symptoms, including sneezing; runny nose; and red, itchy, tearing eyes. It is also used to treat hives. Desloratadine is in a class of medications called antihistamines. It works by blocking histamine, a substance in the body that causes allergic symptoms. Desloratadine may cause less drowsiness than other antihistamines.
How this medication should be used
Desloratadine comes as a tablet and an orally disintegrating tablet to take by mouth. It is usually taken once a day with or without food. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take desloratadine exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.
To take the orally disintegrating tablet, use dry hands to peel back the foil packaging. Immediately take out the tablet and place it on your tongue. The tablet will quickly dissolve and can be swallowed with saliva. Orally disintegrating tablets may be taken with or without water.
Other uses for this medicine
This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.
Special precautions
Before taking desloratadine:
- tell your doctor and pharmacist if you are allergic to desloratadine, loratadine (Claritin), or any other medications.
- tell your doctor and pharmacist what prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking.
- tell your doctor if you have or have ever had kidney or liver disease or phenylketonuria (for orally disintegrating tablets).
- tell your doctor if you are pregnant, plan to become pregnant, or are breast-feeding. If you become pregnant while taking desloratadine, call your doctor.
Special dietary instructions
Unless your doctor tells you otherwise, continue your normal diet.
What to do if you forget a dose
Take the missed dose as soon as you remember it. However, if it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.
Side effects
Minor side effects
Desloratadine may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:
- headache
- upset stomach
- dizziness
- sore throat
- dry mouth
- muscle pain
- extreme tiredness
- painful menstruation
Severe side effects
Some side effects can be serious. The following symptom is uncommon, but if you experience it, call your doctor immediately:
- difficulty breathing
Desloratadine may cause other side effects. Call your doctor if you have any unusual problems while taking this medication.
If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online [at http://www.fda.gov/MedWatch/report.htm] or by phone [1-800-332-1088].
Storage conditions needed for this medication
Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from excess heat and moisture (not in the bathroom). Throw away any medication that is outdated or no longer needed. Talk to your pharmacist about the proper disposal of your medication.
In case of emergency/overdose
In case of overdose, call your local poison control center at 1-800-222-1222. If the victim has collapsed or is not breathing, call local emergency services at 911.
Other information
Keep all appointments with your doctor.
Do not let anyone else take your medication. Ask your pharmacist any questions you have about refilling your prescription.
Brand names
- Clarinex®
- Clarinex® Reditabs®